#USA #Los Angeles #Schall Law Firm #Securities Fraud #uniQure N.V.

Investors Can Lead the Charge in uniQure N.V. Securities Fraud Lawsuit

The Schall Law Firm has issued a call to action for investors in uniQure N.V. (NASDAQ: QURE), reminding them of an ongoing class action lawsuit concerning serious allegations of securities fraud. The lawsuit aims to empower shareholders who purchased securities between September 24, 2025, and October 31, 2025. This initiative underscores the importance of investor rights within the complex financial landscape.

Legal Foundation for the Lawsuit

This case specifically pertains to alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, as regulated by the U.S. Securities and Exchange Commission (SEC). This framework outlines the legal obligations companies have toward their shareholders, including the accuracy and integrity of information disclosed.

The Class Period's Background

The pertinent events during the class period brought concerns to light regarding uniQure's public disclosures. Reports indicate that uniQure may have produced false and misleading statements regarding attempts to secure full approval for its latest product line. Specific allegations focus on the company's failure to secure comprehensive FDA approval for a pivotal study, posing risks of postponements in their Biologics License Application (BLA) timeline. Investors believe that these inaccuracies misled them about the company's prospects.

Call to Action for Affected Investors

Affected investors are encouraged to reach out to the Schall Law Firm by April 13, 2026, in order to participate in the lawsuit and to discuss their rights. Potential plaintiffs can contact Brian Schall directly at the firm's office in Los Angeles or via their designated channels. While the class has yet to receive certification, it is critical for investors to act proactively if they wish to seek recovery for their losses.

Legal Representation and Next Steps

The Schall Law Firm has specialized expertise in representing investors in securities class action lawsuits. Nevertheless, it's essential to clarify that until the class is certified, participants are not officially represented by any attorney. Investors should carefully consider their options—however, opting not to participate means remaining an absent class member, with few recourses for loss recovery.

Relevance of Accurate Disclosure

This case sheds light on the critical role of accurate public disclosures in the market. Investors trust that companies will provide honest assessments and factual updates regarding their operations and financial health. Allegations against uniQure illustrate how deviations from this trust can lead to severe repercussions for shareholders, both ethically and financially.

Conclusion: The Power of Collective Action

The opportunity to join this lawsuit underscores the broader theme of collective action in shareholder rights. As the financial landscape continues to evolve, legal initiatives like this one are vital for ensuring transparency and accountability within the business world. Affected investors of uniQure must recognize their rights and leverage the resources available to them through the Schall Law Firm. By doing so, they can contribute to a push for integrity in financial disclosures, ultimately fostering a more trustworthy investment climate.